Blue Trust’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
SL
Blue Trust's ONC Position: Q3 2026 in Review
Blue Trust increased its BeOne Medicines Ltd (ONC) stake by 4.5% in Q3 2026, buying an estimated $12.3K and bringing the position to 841 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #634.
Blue Trust first reported a position in ONC in Q2 2022 and has held it in 18 quarters since. The position peaked at $329K in Q3 2025. 260 funds tracked by Wall St. Rank hold ONC as of Q3 2026.
- Blue Trust held 841 shares of BeOne Medicines Ltd worth $308K as of Q3 2026.
- Blue Trust bought 36 BeOne Medicines Ltd shares in Q3 2026, an estimated $12.3K.
- BeOne Medicines Ltd made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #634 holding.
- Blue Trust first reported a position in BeOne Medicines Ltd in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's BeOne Medicines Ltd position peaked at $329K in Q3 2025.
- 260 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.